Company: BIVIW
Filing Date: 2025-05-15
Form Type: DRS
Source: 0001520138-25-000149
Chunk: 15

Company: BIOVIE INC.
Filing Date: 2025-05-15
Form: DRS
Chunk 15
---
0% of the aggregate number of Units and Pre-Funded Units sold in this offering. Each Representative’s Warrant will have an exercise price of $        per share, is immediately exercisable and will expire on the four- and one-half year anniversary of the date that is 180 days from the date of issuance. The Representative’s Warrants will provide for registration rights (including a one-time demand registration right and unlimited piggyback rights) and customary anti-dilution provisions. |

<div align='center'>7</div>

| Use of proceeds: |     | We intend to use the net proceeds from this offering for working capital and general corporate purposes. See “Use                                                                                                                                                                                                                                                                                                                                                                                       
 of Proceeds” for a more complete description of the intended use of proceeds from this offering.                                                                                                                                                                                                                                                                                                                                                                                                        |
| Risk factors:    |     | Investing in our securities involves a high degree of risk. See “Risk Factors” beginning                                                                                                                                                                                                                                                                                                                                                                                                                
 on page 9 and the similarly titled sections in the documents incorporated by reference into this prospectus for a discussion of the                                                                                                                                                                                                                                                                                                                                                                     
 factors you should consider carefully before you decide to invest in our securities.                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Listing:         |     | Our Common Stock is listed on Nasdaq under the symbol “BIVI.”  There is no established trading market for the Pre-funded Warrants or Warrants. We intend to apply to list the Warrants on Nasdaq under the symbol “BIVIW”. We cannot guarantee that the Warrants will be approved for listing on Nasdaq. We do not intend to list the Pre-funded Warrants on any securities exchange or nationally recognized trading system and do not expect a trading market to develop for the Pre-funded Warrants. |

The number of shares of our Common Stock outstanding before this offering and to be outstanding after this offering is based on 18,562,376 shares of our Common Stock outstanding as of May 5, 2025, and excludes:

| · | 887,129 shares of our Common Stock issuable upon the exercise of outstanding stock options at a weighted 
 average exercise price of $29.47 per share;                                                              |

| · | 9,600,564 shares of our Common Stock issuable upon the exercise of outstanding warrants at a weighted 
 average exercise price of $3.50 per share;                                                            |

| · | 110,539 shares of our Common Stock issuable upon vesting of restricted stock units issued under our equity 
 incentive plan.                                                                                            |

Unless otherwise